Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: RADIATION: Standard of Care Adjuvant Breast Radiation|DRUG: Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)|Alliance for Clinical Trials in Oncology|Eastern Cooperative Oncology Group|SWOG Cancer Research Network